Focal hepatic lesions in Gd-EOB-DTPA enhanced MRI: the atlas

Insights into Imaging - 2012
José Traila Campos1, Claude B. Sirlin2, Jin-Young Choi3
1Department of Radiology, FMUP, Hospital S. João, Alameda Prof. Hernâni Monteiro, Porto, Portugal
2Department of Radiology, UCSD, San Diego, USA
3Department of Radiology, Yonsei University Health System, Seoul, Republic of Korea

Tóm tắt

This article reviews the different technical aspects and pitfalls of gadolinium (Gd)-ethoxibenzyl (EOB)-diethylenetriamine pentaacetic acid (DTPA) and the advantages of the hepatocellular phase (HCP) and defines its specific imaging features of liver lesions. Gd-EOB-DTPA is a contrast agent with combined properties of a conventional non-specific extracellular and a hepatocyte-specific contrast agent. Benign cirrhosis-associated nodules are characterised by isointensity in dynamic imaging and the HCP. Hepatocellular carcinomas (HCCs) usually show hyperenhancement in the arterial phase, with washout in the portal vein pressure (PVP) and hypointensity in the HCP. Among other characteristic findings, we have the mosaic pattern, a capsule, the “nodule-in-nodule” appearance and the satellite nodules. The fibrolamellar HCC is a large enhancing heterogeneous lesion, on a non-cirrhotic liver, with a hypointense scar in every sequence. THIDs (transient hepatic intensity differences) are perfusional alterations, characterised by hyperintensity in the arterial phase, with no alterations in the rest of the sequences including the HCP. Adenoma and focal nodular hyperplasia (FNH) are lesions, occurring more frequently in young women, with brisk arterial enhancement, differentiated by the scar and the uptake of Gd-EOB-DTPA in the HCP. Focal eosinophilic infiltration is a difficult diagnosis, with characteristics such as a non-spherical shape and irregular borders suggesting it. Besides these lesions, in which Gd-EOB-DTPA has a clear advantage, there are a few where the specificities of this agent can be troublesome: haemangiomas, focal fat/sparing, foreign body reaction, cholangiocarcinoma and metastases. Gd-EOB-DTPA is comparable to extracellular agents, and uptake by functioning hepatocytes in the delayed phase provides additional information that further improves detection and characterisation of many hepatic lesions.

Từ khóa


Tài liệu tham khảo

Nam K, Suk K, Jun W, Suk HL, Dae H, Gwang HK, Hyung Il S (2009) Biliary MR imaging with Gd-EOB-DTPA and its clinical applications. Radiographics 29:1707–1724

Reimer P, Schneider G, Schima W (2004) Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications. Eur Radiol 14:559–578

Tsuboyama T, Onishi H, Kim T, Akita H, Hori M, Tatsumi M, Nakamoto A, Nagano H, Matsuura N, Wakasa K, Tomoda K (2010) Hepatocellular carcinoma: hepatocyte-selective enhancement at gadoxetic acid–enhanced MR imaging—correlation with expression of sinusoidal and canalicular transporters and bile accumulation. Radiology 255(3):824–833

Kitao A, Zen Y, Matsui O, Gabata T, Kobayashi S, Koda W, Kozaka K, Yoneda N, Yamashita T, Kaneko S, Nakanuma Y (2010) Hepatocellular carcinoma: signal intensity at gadoxetic acid– enhanced MR imaging—correlation with molecular transporters and histopathologic features. Radiology 256(3):817–826

Seale MK, Catalano OA, Saini S, Hahn PF, Sahani DV (2009) Hepatobiliary–specific MR contrast agents: role in imaging the liver and biliary tree. Radiographics 29:1725–1748

Gandhi SN, Brown MA, Wong JG, Aguirre DA, Sirlin CB (2006) MR contrast agents for liver imaging: what, when, how. Radiographics 26:1621–1636

Sun HY, Lee JM, Shin CI, Lee DH, Moon SK, Kim KW, Han JK, Choi BI (2010) Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (2 cm in diameter) from arterial enhancing pseudolesions special emphasis on hepatobiliary phase imaging. Investig Radiol 45(2):96–103

Zech CJ, Grazioli L, Breuer J, Reiser M, Schoenberg SO (2008) Diagnostic performance and description of morphological features of focal nodular hyperplasia in Gd-EOB-DTPA-enhanced liver magnetic resonance imaging: results of a multicenter trial. Investig Radiol 43(7):504–511

Tajima T, Honda H, Taguchi K et al (2002) Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation. AJR Am J Roentgenol 178:885–897

Roncalli M, Roz E, Coggi G et al (1999) The vascular profile of regenerative and dysplastic nodules of the cirrhotic liver: implications for diagnosis and classification. Hepatology 30:1174–1178

Cruite I, Schroeder M, Merkle EM, Sirlin CB (2010) Gadoxetate disodium–enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195:29–41

Choi JY, Lee HC, Yim JH, Shim JH, Lim HS, Shin YM, Yu ES, Suh DJ (2011) Focal nodular hyperplasia or focal nodular hyperplasia-like lesions of the liver: a special emphasis on diagnosis. J Gastroenterol Hepatol 26(6):1004–1009

Libbrecht L, Cassiman D, Verslype C, Maleux G, Van Hees D, Pirenne J, Nevens F, Roskams T (2006) Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 101:2341–2346

Choi BI, Takayasu K, Han MC (1993) Small hepatocellular carcinoma and associated lesions of the liver: pathology, pathogenesis, imaging findings. AJR Am J Roentgenol 160:1177–1187

Levy AD (2002) Malignant liver tumours. Clin Liver Dis 6:147–164

Hanna RF, Aguirre DA, Kased N, Emery SC, Peterson MR, Sirlin CB (2008) Cirrhosis-associated hepatocellular nodules: correlation of histopathologic and MR imaging features. Radiographics 28:747–769

Huppertz A, Haraida S, Kraus A et al (2005) Enhancement of focal liver lesions at gadoxetic acid-enhanced MR imaging: correlation with histopathologic findings and spiral CT—initial observations. Radiology 234:468–478

Kim SH (2009) Gadoxetic acid–enhanced MRI versus triple-phase MDCT for the preoperative detection of hepatocellular carcinoma. AJR Am J Roentgenol 192:1675–1681

Fujita M, Yamamoto R, Fritz-Zieroth (1996) Contrast enhancement with Gd-EOB-DTPA in MR imaging of hepatocellular carcinoma in mice: a comparison with superparamagnetic iron oxide. J Magn Reson Imaging 6(3):472–477

Shimofusa R (2009) Magnetic resonance imaging of hepatocellular carcinoma: a pictorial review of novel insights into pathophysiological features revealed by magnetic resonance imaging. J Hepatobiliary Pancreat Surg 17(5):583–589

Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium–enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195(1):13–28

Ahn JH, Yu JS, Hwang SW, Chung JJ, Kim JH, Kim KW (2010) Nontumourous arterioportal shunts in the liver: CT and MRI findings considering mechanisms and fate. Eur Radiol 20:385–394

Motosugi U, Ichikawa T, Sou H, Sano K, Tominaga L, Muhi A, Araki T (2010) Distinguishing hypervascular pseudolesions of the liver from hypervascular hepatocellular carcinomas with gadoxetic acid–enhanced MR imaging. Radiology 256(1):151–158

Wanless IR, Mawdsley C, Adams R (1985) On the pathogenesis of focal nodular hyperplasia of the liver. Hepatology 5(6):1194–2000

Kamel IR, Liapi E, Fishman EK (2006) Focal nodular hyperplasia: lesion evaluation using 16-MDCT and 3D CT angiography. AJR Am J Roentgenol 186(6):1587–1596

Grazioli L, Morana G, Federle MP et al (2001) Focal nodular hyperplasia: morphologic and functional information from MR imaging with gadobenate dimeglumine. Radiology 221:731–739

Brancatelli G, Federle MP, Vullierme MP, Lagalla R, Midiri M, Vilgrain V (2006) CT and MR imaging evaluation of hepatic adenoma. J Comput Assist Tomogr 30(5):745–750

Ichikawa T, Federle MP, Grazioli L, Nalesnik M (2000) Hepatocellular adenoma: multiphasic CT and histopathologic findings in 25 patients. Radiology 214(3):861–868

Hur J, Park M, Yu J, Lim J, Hong SW, Kim KW (2005) Focal eosinophilic necrosis versus metastasis in the liver: the usefulness of two-phase dynamic CT. AJR Am J Roentgenol 184:1541–1548

Kim Y, Kim C, Moon W, Cho B, Lee, Lee JM (2005) MRI findings of focal eosinophilic liver diseases. AJR Am J Roentgenol 184:1541–1548

Doo KW, Lee CH, Choi JW, Lee J, Kim KA, Park CM (2009) “Pseudo washout” sign in high-flow hepatic hemangioma on gadoxetic acid contrast-enhanced MRI mimicking hypervascular tumour. AJR Am J Roentgenol 193:W490–W496

Anderson SW, Kruskal JB, Kane RA (2009) Benign hepatic tumours and iatrogenic pseudotumours. Radiographics 29:211–229

Semelka RC, Martin DR, Balci C, Lance T (2001) Focal liver lesions: comparison of dual-phase CT and multisequence multiplanar MR imaging including dynamic gadolinium enhancement. J Magn Reson Imaging 13(3):397–401

Hussain SM, Zondervan PE, IJzermans JN, Schalm SW, Man RA, Krestin GP (2002) Benign versus malignant hepatic nodules: MR imaging findings with pathologic correlation. Radiographics 22:1023–1039

Thông tin
Thông tin xuất bản

Insights into Imaging

Thông tin tác giả